Apretude (cabotegravir) extended-release injection is a long-acting pre-exposure prophylaxis (PrEP) prescription medicine used to prevent HIV infection in people at risk for sexually-acquired HIV exposure. Cabenuva (cabotegravir and rilpivirine) is also a long-acting injection but is used to treat (not prevent) HIV-1 infection.